HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
Over the last 12 months, insiders at HilleVax, Inc. have bought $149,550 and sold $2.11M worth of HilleVax, Inc. stock.
On average, over the past 5 years, insiders at HilleVax, Inc. have bought $15.07M and sold $493.96M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Frazier Life Sciences X, L.P. (10 percent owner) — $128,325. McLoughlin Sean (Chief Operating Officer) — $21,225.
The last purchase of 8,850 shares for transaction amount of $128,325 was made by Frazier Life Sciences X, L.P. (10 percent owner) on 2024‑04‑04.
2024-05-22 | Sale | director | 6,000 0.0126% | $14.73 | $88,372 | -86.78% | ||
2024-05-21 | Sale | director | 6,000 0.0118% | $14.21 | $85,230 | -87.08% | ||
2024-05-20 | Sale | director | 6,000 0.0129% | $15.45 | $92,689 | -87.09% | ||
2024-05-03 | Sale | director | 723 0.0015% | $14.15 | $10,233 | -86.11% | ||
2024-05-02 | Sale | director | 6,000 0.0121% | $14.01 | $84,081 | -86.48% | ||
2024-05-01 | Sale | director | 175 0.0004% | $14.03 | $2,456 | -86.00% | ||
2024-04-05 | Sale | director | 6,000 0.012% | $14.44 | $86,640 | -86.78% | ||
2024-04-04 | Sale | director | 6,000 0.0122% | $14.71 | $88,245 | -86.72% | ||
2024-04-04 | 10 percent owner | 8,850 0.0178% | $14.50 | $128,325 | -86.72% | |||
2024-04-03 | Sale | director | 6,000 0.0122% | $14.93 | $89,582 | -86.98% | ||
2024-03-28 | Chief Operating Officer | 1,250 0.0026% | $16.98 | $21,225 | -88.36% | |||
2024-03-20 | Sale | director | 6,000 – | $164,221.00 | $985.33M | -87.90% | ||
2024-03-19 | Sale | director | 6,000 0.0126% | $17.42 | $104,492 | -88.75% | ||
2024-03-18 | Sale | director | 6,000 0.0129% | $17.66 | $105,937 | -88.70% | ||
2024-03-08 | Sale | director | 6,000 0.0128% | $18.66 | $111,959 | -89.28% | ||
2024-03-07 | Sale | director | 6,000 0.0124% | $18.37 | $110,213 | -89.38% | ||
2024-03-06 | Sale | director | 6,000 0.0128% | $18.95 | $113,701 | -89.48% | ||
2024-02-22 | Sale | director | 6,000 0.0127% | $15.05 | $90,312 | -19.53% | ||
2024-02-21 | Sale | director | 6,000 0.0126% | $14.92 | $89,495 | -19.15% | ||
2024-02-20 | Sale | director | 6,000 0.0127% | $14.88 | $89,272 | -18.92% |
Frazier Life Sciences X, L.P. | 10 percent owner | 8544187 17.1549% | $2.06 | 1 | 0 | |
HERSHBERG ROBERT | See Remarks | 953831 1.9151% | $2.06 | 0 | 1 | |
Kohli Aditya | director | 764878 1.5357% | $2.06 | 0 | 19 | |
Borkowski Astrid | Chief Medical Officer | 161260 0.3238% | $2.06 | 0 | 6 | |
Maltbie Shane | Chief Financial Officer | 40656 0.0816% | $2.06 | 0 | 1 | |
McLoughlin Sean | Chief Operating Officer | 1250 0.0025% | $2.06 | 1 | 0 | |
Heron Patrick J | 8535337 17.1371% | $2.06 | 1 | 0 | <0.0001% |
Frazier Life Sciences Management L P | $162.67M | 19.67 | 9.78M | 0% | +$0 | 7.35 | |
Deerfield Management | $66.59M | 8.05 | 4M | 0% | +$0 | 0.16 | |
T Rowe Price Investment Management Inc | $50.92M | 6.16 | 3.06M | +110.6% | +$26.74M | 0.03 | |
Deep Track Capital Lp | $42.78M | 5.17 | 2.57M | -11.29% | -$5.45M | 0.2 | |
Vr Adviser Llc | $34.51M | 4.17 | 2.08M | 0% | +$0 | 1.68 | |
Franklin Templeton Investments | $30.84M | 3.73 | 1.85M | +0.43% | +$133,040.00 | 0.01 | |
The Carlyle Group | $30.5M | 3.7 | 1.84M | 0% | +$0 | 1.31 | |
BlackRock | $29.94M | 3.62 | 1.8M | +1.37% | +$404,774.19 | <0.01 | |
The Vanguard Group | $22.66M | 2.74 | 1.36M | -6.97% | -$1.7M | <0.0001 | |
StepStone Group | $13.75M | 1.66 | 826,569 | 0% | +$0 | 2.93 | |
Samsara Biocapital Llc | $13.29M | 1.61 | 799,274 | 0% | +$0 | 2.07 | |
Millennium Management LLC | $11.25M | 1.36 | 676,566 | New | +$11.25M | 0.01 | |
Citadel Advisors LLC | $10.8M | 1.31 | 649,376 | -10.35% | -$1.25M | 0.01 | |
Geode Capital Management | $10.34M | 1.25 | 621,817 | +5.19% | +$510,156.76 | <0.01 | |
Qiming U S Ventures Management Llc | $9.29M | 1.12 | 558,923 | 0% | +$0 | 10.36 | |
State Street | $8.13M | 0.98 | 488,734 | +17.13% | +$1.19M | <0.0001 | |
Deutsche Bank | $5.14M | 0.62 | 309,304 | +180.37% | +$3.31M | <0.01 | |
ACUTA CAPITAL PARTNERS LLC | $4.17M | 0.5 | 250,609 | -22.8% | -$1.23M | 2.71 | |
Northern Trust | $4.06M | 0.49 | 243,948 | -1.5% | -$61,946.76 | <0.01 | |
Charles Schwab | $3.43M | 0.42 | 206,266 | -1.2% | -$41,691.42 | <0.01 | |
Walleye Capital | $2.36M | 0.29 | 142,182 | -30.53% | -$1.04M | 0.01 | |
Alger | $2.06M | 0.25 | 124,122 | -5.57% | -$121,814.76 | 0.01 | |
Ensign Peak Advisors Inc | $1.96M | 0.24 | 117,746 | 0% | +$0 | <0.01 | |
Dimensional Fund Advisors | $1.93M | 0.23 | 115,912 | +79.53% | +$853,900.81 | <0.0001 | |
683 Capital Management Llc | $1.88M | 0.23 | 113,000 | -6.77% | -$136,366.00 | 0.2 | |
Bridger Management Llc | $1.8M | 0.22 | 108,200 | New | +$1.8M | 0.81 | |
Adage Capital Partners Gp L L C | $1.23M | 0.15 | 74,220 | -62.6% | -$2.07M | <0.01 | |
Barclays | $1.2M | 0.15 | 72,270 | +81.09% | +$538,247.18 | <0.01 | |
BNY Mellon | $1.16M | 0.14 | 69,455 | -5.68% | -$69,529.99 | <0.0001 | |
Morgan Stanley | $1.05M | 0.13 | 63,033 | -86.15% | -$6.52M | <0.0001 | |
Wellington Management Company | $1.03M | 0.13 | 61,923 | New | +$1.03M | <0.0001 | |
Nuveen | $805,058.00 | 0.1 | 48,410 | 0% | +$0 | <0.0001 | |
JPMorgan Chase | $782,808.00 | 0.1 | 47,072 | +171.43% | +$494,410.30 | <0.0001 | |
Ubs Oconnor Llc | $759,592.00 | 0.09 | 45,676 | -25.19% | -$255,819.33 | 0.04 | |
Swiss National Bank | $635,266.00 | 0.08 | 38,200 | 0% | +$0 | <0.0001 | |
Two Sigma | $625,654.00 | 0.08 | 37,622 | +25.13% | +$125,639.68 | <0.01 | |
Td Asset Management Inc | $585,975.00 | 0.07 | 35,236 | +90.18% | +$277,854.19 | <0.01 | |
RhumbLine Advisers | $558,508.00 | 0.07 | 33,585 | +5.84% | +$30,798.18 | <0.01 | |
Jane Street Capital | $525,774.00 | 0.06 | 31,616 | +130.98% | +$298,142.59 | <0.01 | |
Martingale Asset Management L P | $482,803.00 | 0.06 | 29,032 | +0.11% | +$532.16 | 0.01 | |
UBS | $479,958.00 | 0.06 | 28,861 | -9.55% | -$50,704.82 | <0.0001 | |
D. E. Shaw & Co. | $468,284.00 | 0.06 | 28,159 | New | +$468,284.00 | <0.0001 | |
Bank of America | $465,806.00 | 0.06 | 28,010 | -39.37% | -$302,516.14 | <0.0001 | |
State of Wisconsin Investment Board | $454,465.00 | 0.06 | 27,328 | +105.24% | +$233,036.38 | <0.01 | |
Standard Life | $449,010.00 | 0.05 | 27,000 | 0% | +$0 | <0.01 | |
Renaissance Technologies | $429,000.00 | 0.05 | 25,800 | New | +$429,000.00 | <0.01 | |
New York Life Investment Management Llc | $374,375.00 | 0.05 | 22,512 | New | +$374,375.00 | <0.01 | |
Stifel | $346,687.00 | 0.04 | 20,847 | New | +$346,687.00 | <0.0001 | |
CalSTRS | $333,132.00 | 0.04 | 20,032 | -7.01% | -$25,111.29 | <0.0001 | |
Woodline Partners LP | $315,804.00 | 0.04 | 18,990 | New | +$315,804.00 | <0.01 |